GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cannabix Technologies Inc (OTCPK:BLOZF) » Definitions » Net Current Asset Value

Cannabix Technologies (Cannabix Technologies) Net Current Asset Value : $0.03 (As of Jan. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Cannabix Technologies Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Cannabix Technologies's net current asset value per share for the quarter that ended in Jan. 2024 was $0.03.

The historical rank and industry rank for Cannabix Technologies's Net Current Asset Value or its related term are showing as below:

BLOZF' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 3.5   Med: 9.47   Max: 32.14
Current: 9.67

During the past 12 years, the highest Price-to-Net-Current-Asset-Value Ratio of Cannabix Technologies was 32.14. The lowest was 3.50. And the median was 9.47.

BLOZF's Price-to-Net-Current-Asset-Value is ranked worse than
74.11% of 591 companies
in the Medical Devices & Instruments industry
Industry Median: 4.97 vs BLOZF: 9.67

Cannabix Technologies Net Current Asset Value Historical Data

The historical data trend for Cannabix Technologies's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabix Technologies Net Current Asset Value Chart

Cannabix Technologies Annual Data
Trend Apr14 Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.07 0.06 0.07 0.06 0.04

Cannabix Technologies Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.04 0.03 0.03

Competitive Comparison of Cannabix Technologies's Net Current Asset Value

For the Medical Devices subindustry, Cannabix Technologies's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabix Technologies's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cannabix Technologies's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Cannabix Technologies's Price-to-Net-Current-Asset-Value falls into.



Cannabix Technologies Net Current Asset Value Calculation

Cannabix Technologies's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Apr. 2023 is calculated as

Net Current Asset Value Per Share(A: Apr. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(4.885-0.176-0-0)/114.144
=0.04

Cannabix Technologies's Net Current Asset Value (NCAV) per share for the quarter that ended in Jan. 2024 is calculated as

Net Current Asset Value Per Share(Q: Jan. 2024 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(3.811-0.08-0-0)/114.144
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabix Technologies  (OTCPK:BLOZF) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Cannabix Technologies Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of Cannabix Technologies's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabix Technologies (Cannabix Technologies) Business Description

Traded in Other Exchanges
Address
501-3292 Production Way, Burnaby, BC, CAN, V5A 4R4
Cannabix Technologies Inc is in the development of marijuana breathalyzer. It is developing breath testing technologies that can be used at the point of care to detect recent use of marijuana. It is also developing its technology to help employers, law enforcement, government and the public, when marijuana is becoming legal for recreational and medicinal use in many jurisdictions globally. The FAIMS device is designed to operate both independently or coupled in tandem directly to a mass spectrometer, used in forensic labs. The THC Breath Analyzer is a point of care breath testing tool for the rapid detection of recent cannabis use.

Cannabix Technologies (Cannabix Technologies) Headlines